amyloidotic

amyloidotic

adjective Referring to amyloid or amyloidosis.
References in periodicals archive ?
Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
Ueda et al., "DJ-1 degrades transthyretin and an inactive form of DJ-1 is secreted in familial amyloidotic polyneuropathy," International Journal of Molecular Medicine, vol.
The first reported case came from Portugal where the liver from a patient with familial amyloidotic polyneuropathy (FAP) was used for non-FAP patient [1].
Ando et al., "Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation," Amyloid, vol.
The elevated expression or activation of MMP-9 was clinically found to be associated with brain edema [14] and familial amyloidotic polyneuropathy [15].
The predictive testing (PST) model for late-onset neurodegenerative diseases such as Huntington's disease (HD), a rare disorder with a prevalence of ~1-7 in 100,000 individuals of European ancestry (Ramos et al., 2015), has been implemented and adapted for other late-onset diseases around the world (Hawkins, Ho, & Hayden, 2011), namely, Machado-Joseph disease (MJD) and Familial Amyloidotic Polyneuropathy (FAP), two Portuguese monogenic, autosomal and dominant diseases (Sequeiros et al., 2006), with a severe neurodegenerative evolution and no effective cure.
Risk perception in subjects at-risk for Familial Amyloidotic Polyneuropathy
Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy.
Cardoso et al., "Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative," Biochemical Journal, vol.
Lattice corneal dystrophy, gelsolin type--Meretoja's syndrome--is also called lattice corneal dystrophy type 2 (LCD2) or familial amyloidotic polyneuropathy (FAP) type IV and is an autosomal dominant inherited disease caused by a mutation G654A or G654T in the gelsolin gene at 9q32-34 [1-3].
The product is intended for the treatment of mediated amyloidosis in patients with familial amyloidotic polyneuropathy (FAP).